The independent source for health policy research, polling, and news.
381-400 of 659 results
Once a tiny specialty that drew mostly psychiatrists, addiction medicine is expanding its accredited training to include primary care residents and "social justice warriors" who see it as a calling.
A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
A significant portion of syphilis transmission in heterosexuals occurs among people who use drugs, particularly methamphetamine, a new report shows. Public health officials warn that you can’t treat one problem without addressing the other.
President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it’s welcomed by researchers and advocates, it’s not a lot of money.
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners’ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner.
As the number of people who inject drugs has soared, the rate of hepatitis C infection has climbed steeply, too, because the disease can be tied to sharing needles. Yet many drug patients are not checked for the virus that can damage the liver.
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
For over a decade, federal health officials have recommended the practice, known as expedited partner therapy. It is allowed in most states, but many doctors don’t do it — either because of legal or ethical concerns, or because they are unaware of it.
The program that provides health care for about half of the U.S. territory’s population cannot afford to cover the drugs.
In a recent study of patients treated by emergency medical responders in Oregon, black patients were 40 percent less likely to get pain medicine than their white peers. Why?
The small federal program once based funding on an area’s cumulative number of cases. It will now be more responsive to places where new outbreaks are occurring.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss how the Democrats’ takeover of the House and other results from the Nov. 6 elections might affect health care, and what Congress may have in store for the lame-duck session.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”
Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
California frequently innovates to address its wide-ranging health care needs, but it has not always achieved its aims. A series of articles in the journal Health Affairs shows, among other things, that efforts to care for HIV patients, provide better access to reproductive services for low-income women and fill gaps in primary care have sometimes fallen flat.
© 2026 KFF